Azelis Acquires Italy’s Eurotrading

Azelis has entered into an agreement to buy Eurotrading, an Italian specialty chemicals distributor with an extensive product portfolio in actives, emollients and emulsifiers.

Based in Veggiano, Eurotrading has about 32 employees and operates three R&D laboratories. Azelis said the acquisition reinforces its leading footprint in the thriving Italian market for personal care, as well as in the broader life sciences segment.

Marco Gerosa, managing director at Azelis Italy, commented: “Joining forces with Eurotrading furthers our growth in the personal care market across Italy and Europe, Middle East and Africa. In partnerships with leading international principals, Eurotrading offers innovative solutions that perfectly complement Azelis' product portfolio, and their strong technical sales team will bring great contributions to the business.”

Financial terms of the deal, which is expected to close in the fourth quarter of 2022, were not disclosed. All staff will transfer to Azelis once the transaction has completed.

Azelis’s last acquisition in Italy was in January 2021 when it agreed to take over Came Chemical Mineral and Engineering. Came specialized in distributing chemicals for friction and sintering applications, coatings, adhesives, sealants and elastomers (CASE), and cosmetics.

Author: Elaine Burridge, Freelance Journalist

© Shutterstock/ cavava
© Shutterstock/ cavava

Company

Logo:

Azelis Corporate Services NV

12 box 6, Posthofbrug
2600 Antwerpen
Belgium

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.